The deal is expected to close within the next six weeks, subject to regulatory approvals. AMS expects to fund the transaction from existing cash and available credit lines with no additional transaction-based financing.

"We will leverage AMS' technical and operational expertise, and profit from the global access to potential new customers to realize our full growth potential," said Luc de Mey, CEO of Cmosis.

The acquisition will strengthen AMS' position as a provider of sensors for industry, the Internet of Things and medical diagnostics, said CEO Kirk Laney.

Founded in 2007, Cmosis operates as a fabless semiconductor supplier from locations in Belgium, Germany, Portugal and the U.S., and has more than 110 employees. It expects to generate full-year 2015 revenues of approximately €60 million (about $64.1 million) and continue growth in 2016.